HEPATOCARTRIDGE
DEAD

Serial Number

79334988

Owner

CYPRIO

Filing Date

Dec 20, 2021

Add to watchlist:

No watchlists yet
View on USPTO

HEPATOCARTRIDGE Trademark

Serial Number: 79334988

HEPATOCARTRIDGE is a trademark filed by CYPRIO on December 20, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

CYPRIO (4 trademarks)

10 rue Vauquelin

Entity Type: 34

Trademark Details

Filing Date

December 20, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical products, medical and veterinary preparations; hygienic products for medicine; dietetic substances and foodstuffs for medical or veterinary use, food for babies; food supplements for humans and animals; plasters, materials for dressings; material for dental fillings and dental impressions; disinfectants; products for destroying vermin; fungicides, herbicides; bacterial, bacteriological, biological or chemical preparations for medical or veterinary use; preparations of micro-organisms, cells, stem cells and bacteria for medical or veterinary use; diagnostic preparations for medical or veterinary use; chemical, biochemical or biological reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; in vitro diagnostic reagents and agents for medical or veterinary use; cultures of biological tissues and microorganisms for medical or veterinary use; micro-biological culture media for medical or veterinary use; cells and stem cells for medical or veterinary use; cell culture media for medical or veterinary use; biological preparations for cell culture for medical or veterinary use; tissues and matrices of tissues and organs for medical or veterinary use; chemical products for the development of pharmaceutical and biotechnological products for medical or veterinary use; surgical implants made of living tissue; grafts [living tissues]; living tissues, micro-tissues and organs for medical or veterinary use; preparations for 3D bio-printing of living tissues, micro-tissues and organs for medical or veterinary use; pharmaceutical products for tissue regeneration, tissue repair or tissue processing for medical or veterinary use; testing, sampling and diagnostic kits for medical or veterinary use; testing kits comprising reagents, chemical, biochemical, biological or pharmaceutical agents and products for testing for medical and veterinary use; chemical, biochemical or biological preparations, and chemical reagents and test kits therefor for medical or veterinary use for the development of pharmaceutical products and medicines, for biological tissue repair, replacement of organs or development of artificial organs; test kits for measuring gene expression, secretion and protein activity for medical or veterinary use; chemical products for use in encapsulation and coating of active ingredients and pharmaceutical substances for medical or veterinary use; chemical products for cell encapsulation for medical or veterinary use; chemical products for three dimensional cell culture for medical or veterinary use; cartridges containing tissues, micro-tissues or organs for transplantation for medical or veterinary use; cartridges containing tissues, micro-tissues or organs for integration for integration into bio-artificial extra-corporal organ machines and apparatus for medical or veterinary use; biological products encapsulated with cell cultures for medical, veterinary or pharmaceutical or veterinary use; cells, stem cells and encapsulated or co-encapsulated microorganisms secreting biological products for medical, pharmaceutical or veterinary use; encapsulated biological products with liver cells for medical, pharmaceutical or veterinary use; encapsulated liver cells secreting biological products for medical, pharmaceutical or veterinary use

Chemical products for use in industry, science and for research; bacterial, bacteriological, biological, chemical or biochemical preparations for use in industry, science and for research; preparations of micro-organisms, cells, stem cells and bacteria for use in industry, science and for research; chemical products for analyses in laboratories; diagnostic preparations for use in industry, science and for research; chemical, biochemical or biological reagents for use in industry, science and for research; in vitro diagnostic reagents and agents for use in industry, science and for research; cultures of biological tissues and micro-organisms for use in industry, science and for research; micro-biological culture media for use in industry, science and for research; stem cells for use in industry, science and for research; cell culture media for use in industry, science and for research; biological preparations for cell cultures for use in industry, science and for research; tissues and matrices of tissues and organs for scientific, medical and pharmaceutical research; chemical products for the development of biotechnological products for use in industry, science and for research; testing, sampling and diagnostic kits for use in industry, science and for research; chemical test kits comprising reagents, chemical, biochemical or biological agents and products for testing for use in industry, science and for research; chemical, biochemical or biological preparations, and chemical reagents and test kits therefor for research and development relating to pharmaceutical products and medicines, biological tissue repair, replacement of organs or development of artificial organs; test kits for measuring gene expression, secretion and protein activity for use in industry, science and for research; chemical products for encapsulation or coating of active chemical ingredients for use in industry, science and for research; chemical products for cell encapsulation for use in industry, science and for research; chemical products for three-dimensional cell culture for use in industry, science and for research; encapsulated biological products with cell cultures for scientific use for diagnosis and for research; encapsulated or co-encapsulated cells, stem cells and microorganisms secreting biological products for scientific use for diagnosis and for research; encapsulated biological products with liver cultures for scientific use for diagnosis and for research; encapsulated liver cells secreting biological products for scientific use for diagnosis and for research

Surgical apparatus and instruments; medical apparatus and instruments; veterinary apparatus and instruments; artificial limbs; artificial internal organs; artificial implants; medical implants; artificial surgical implants; biodegradable implants for bone fixation; prostheses; testing apparatus for medical use; diagnostic apparatus for medical use; apparatus for the regeneration of stem cells for medical use; containers for transporting samples containing living human cells; containers for transporting tissues, micro-tissues, cells, stem cells, microorganisms or organs for medical, veterinary or pharmaceutical use; cartridges for haemoperfusion; bio-artificial extra-corporal organ machines and apparatus for medical, veterinary or pharmaceutical use; machines and apparatus for holding cartridges containing tissue, micro-tissues, cells, stem cells, microorganisms or organs for transplantation for medical or veterinary use; medical apparatus and instruments for interstitial thermotherapy of biological tissues

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 26, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 27, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 4, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 4, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 27, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 9, 2023 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 3, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 3, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 3, 2023 ABN2
REFUSAL PROCESSED BY IB
Jan 9, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 19, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 19, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 8, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2022 REPR